Kevin Leshuk BA

Kevin Leshuk, a graduate of McMaster University, has over 25+ years of Canadian-based biopharmaceutical experience, having held executive-level leadership roles within Pharmacia, Pfizer, Roche, and Celgene. Mr. Leshuk is recognized as a commercialization expert within the Life Sciences community, having built and led teams that have launched some of the most successful medicines introduced to Canada over the last two decades. He has held significant corporate leadership roles within Pfizer and Celgene and was an active Executive Board member with BIOTECanada.

In 2021, he founded FORUS Therapeutics Inc., a Toronto-based commercial-stage Specialty Pharmaceutical company. Since the company's launch, the FORUS team has successfully launched XPOVIO for patients living with Multiple Myeloma. FORUS looks to expand on this recent success and is actively sourcing additional novel therapeutics for Canadians living with Cancer. Kevin is a passionate champion for the Canadian Life Sciences Industry and access to medicines for all Canadians.